Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AKR1C3 | P42330 | 7/20 | 0.52 |
| ▸ | CASP3 | P42574 | 1/20 | 0.49 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.49 |
| ▸ | GLA | P06280 | 1/20 | 0.49 |
| ▸ | MAOB | P27338 | 6/20 | 0.49 |
| ▸ | AR | P10275 | 2/20 | 0.47 |
| ▸ | CBR1 | P16152 | 2/20 | 0.47 |
| ▸ | KCNK3 | O14649 | 2/20 | 0.47 |
| ▸ | KCNK9 | Q9NPC2 | 2/20 | 0.47 |
| ▸ | NPC1 | O15118 | 2/20 | 0.46 |
| ▸ | RAB9A | P51151 | 2/20 | 0.46 |
| ▸ | MAOA | P21397 | 2/20 | 0.46 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.46 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.46 |
| ▸ | AKR1C1 | Q04828 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL981428 | 0.94 | ALDH1A1 (0.53) | CASP3ALDH1A1GLAMAOBKCNK3 | |
| SCHEMBL982817 | 0.91 | CASP3 (0.61) | CASP3ALDH1A1GLAMAOBKCNK3 | |
| SCHEMBL977971 | 0.85 | ALDH1A1 (0.59) | CASP3ALDH1A1GLAMAOBKCNK3 | |
| SCHEMBL979711 | 0.85 | CASP3 (0.48) | CASP3ALDH1A1GLAMAOBKCNK3 | |
| SCHEMBL980389 | 0.82 | CASP3 (0.53) | CASP3MAOBKCNK3KCNK9NPC1 | |
| SCHEMBL979435 | 0.81 | CASP3 (0.49) | CASP3ALDH1A1GLAMAOBKCNK3 | |
| SCHEMBL979709 | 0.81 | CASP3 (0.53) | CASP3MAOBKCNK3KCNK9NPC1 | |
| SCHEMBL978586 | 0.80 | ALDH1A1 (0.56) | AKR1C3CASP3ALDH1A1GLAMAOB | |
| SCHEMBL980797 | 0.80 | AKR1C3 (0.50) | AKR1C3CASP3ALDH1A1GLAMAOB | |
| SCHEMBL980458 | 0.80 | ALDH1A1 (0.55) | CASP3ALDH1A1GLAKCNK3KCNK9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20110021522-A1 | ACTIVATORS OF EXECUTIONER PROCASPASES 3, 6 AND 7 | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2011-01-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110021522-A1 | ACTIVATORS OF EXECUTIONER PROCASPASES 3, 6 AND 7 | CASP7, CASP3, CASP6 | AKR1C3 3154/4885CASP3 2/4885ALDH1A1 2806/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.